Health Economics
201 – 210 of 309
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Svensk njurtransplantation. Hälso- och sjukvårdens kostnader
och en diskussion om kostnadseffektivitet
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Evaluation of a School-Based Program Aimed at Preventing Depressive Symptoms in Adolescents
(
- Contribution to journal › Article
- 2014
-
Mark
Willingness to pay for a new drug delivery in Parkinson patients.
(
- Contribution to journal › Article
-
Mark
Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.
2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders 5(2). p.591-607(
- Contribution to journal › Article
-
Mark
Towards a Health Economic Simulation Model of Type 2 Diabetes in Sweden
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations.
(
- Contribution to journal › Article
-
Mark
Overall, gender and social inequalities in suicide mortality in Iran, 2006-2010: a time trend province-level study.
(
- Contribution to journal › Article
-
Mark
Health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden.
(
- Contribution to journal › Article
-
Mark
Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden
(
- Contribution to journal › Article
-
Mark
Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder.
(
- Contribution to journal › Article